{
    "type": "ETF",
    "ucits": true,
    "fund_name": "L&G FTSE 100\u00ae Leveraged (Daily 2x) UCITS ETF",
    "investment_objective": "To track the performance of the FTSE 100\u00ae Daily Leveraged Index, which aims to reflect twice the daily percentage change of the FTSE 100\u00ae Net Dividend Total Return Index, less financing costs and fees.",
    "primary_asset_class": "Equity",
    "geographic_focus": "United Kingdom",
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": true,
    "inverse": false,
    "complex_factors": [
        "Unfunded total return swaps",
        "Daily 2x leverage",
        "Synthetic replication",
        "Counterparty risk",
        "Leveraged index with daily reset and compounding effects"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via unfunded total return swap agreements with swap counterparties (investment banks) to achieve its investment objective. The Fund targets a 2x leveraged exposure to the FTSE 100\u00ae Net Dividend Total Return Index through a daily leveraged index, which resets daily and introduces compounding effects that can cause deviation from the underlying index over periods longer than one day. The Fund explicitly states the use of swaps, counterparty risk, and leverage. The risk rating is high (7 out of 7 in KIID, 6 out of 7 in PRIIPs), reflecting the leveraged nature and derivative exposure. The Fund is UCITS compliant but uses complex instruments and strategies that are not straightforward for retail investors to understand. The PRIIPs KID highlights the short-term holding recommendation and magnified losses due to leverage. The fact sheet confirms synthetic replication, unfunded swaps, and daily leverage reset. There are no capital protection features. Costs include ongoing charges and transaction costs related to derivative usage. These factors combined meet MiFID II criteria for a complex financial instrument.",
    "risk_level_assessment": "The Fund is rated at the highest risk levels (7/7 in KIID and 6/7 in PRIIPs), consistent with the use of leverage and derivatives. The risk profile aligns with the complexity classification, indicating significant potential for loss and the need for investor understanding of leveraged synthetic products.",
    "notes": "Although the Fund is UCITS compliant, the use of synthetic replication with unfunded total return swaps, daily 2x leverage, and the associated counterparty and compounding risks make it complex under MiFID II. The product is designed for short-term investors who understand leverage risks and is not suitable for long-term holding by retail investors without specific knowledge."
}